Application of process chemistry and SAR modelling to the evaluation of health findings of lower olefins

Citation
Mg. Bird et al., Application of process chemistry and SAR modelling to the evaluation of health findings of lower olefins, CHEM-BIO IN, 135, 2001, pp. 571-584
Citations number
32
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CHEMICO-BIOLOGICAL INTERACTIONS
ISSN journal
00092797 → ACNP
Volume
135
Year of publication
2001
Pages
571 - 584
Database
ISI
SICI code
0009-2797(20010601)135:<571:AOPCAS>2.0.ZU;2-B
Abstract
Epidemiology studies show increased leukemia mortality among styrene butadi ene rubber (SBR) workers but not among butadiene monomer production employe es. A detailed review of the SBR manufacturing process indicates that sodiu m dime thyldithiocarbamate (DMDTC) introduced into the SBR manufacturing pr ocess for a period in the 1950s coincides with increased leukemia mortality . Using the Computer-Optimized Molecular Parametric Analysis of Chemical To xicity (COMPACT), we assessed the enzyme (cytochrome P450) substrate specif icity of an olefin series including 1,3-butadiene (BD) and also modeled its interaction with DMDTC. These analyses showed correlation of a structural/ electronic parameter - the COMPACT radius - with the presence or absence of cytogenetic activity and also found that DMDTC would inhibit the oxidative metabolism of BD at least at high concentrations. Both DMDTC and its dieth yl analog (DEDTC) bind with CYP 2E1 and CYP 2A6. Both of these isoforms are important in the initial oxidative metabolism of butadiene and other olefi ns. In co-exposure studies in mice of DMDTC with BD or with epoxybutene (EB ), we found that there was a reduced increase in genotoxic activity based o n micronuclei induction compared with BD or EB exposure alone. Treatment wi th DMDTC significantly increased the protein carbonyl contents of hepatic m icrosomes compared with that of controls, a finding that may be related to DMDTC's activity as a prooxidant. Co-exposure with DMDTC and EB increased h epatic microsomal carbonyls to levels significantly greater than those of D MDTC-treated mice, while EB administration in the absence of DMDTC did not change protein carbonyls relative to those of controls. The increase in hep atic microsomal protein carbonyls suggests that DMDTC may modulate EB metab olism towards the formation of reactive intermediates that react with prote ins. The present molecular modeling and mechanistic studies suggest that co -exposure of BD and DMDTC is a plausible biological hypothesis regarding in creased leukemia risk among SBR workers. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.